Encapsulation of the HSP-90 Chaperone Inhibitor 17-AAG in Stable Liposome Allow Increasing the Therapeutic Index as Assessed, in vitro, on Leishmania (L) amazonensis Amastigotes-Hosted in Mouse CBA Macrophages

The current long-term treatment for leishmaniasis causes severe side effects and resistance in some cases. An evaluation of the anti-leishmanial potential of an HSP90-inhibitor, 17-allylamino-17-demethoxygeldanamycin (17-AAG), demonstrated its potent effect against Leishmania spp. in vitro and in vi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Cell Infect Microbiol
Päätekijät: Petersen, Antonio Luis de Oliveira Almeida, Campos, Thiers A., Dantas, Diana Angélica dos Santos, Rebouças, Juliana de Souza, da Silva, Juliana Cruz, de Menezes, Juliana P. B., Formiga, Fábio R., de Melo, Janaina V., Machado, Giovanna, Veras, Patrícia S. T.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2018
Aiheet:
Cellular and Infection Microbiology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6126448/
https://ncbi.nlm.nih.gov/pubmed/30214897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcimb.2018.00303
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia